Status:

UNKNOWN

Treatment of Atrophic Gastritis After HP Eradication With Modified Liujunzi Decoction Based on Syndrome Differentiation

Lead Sponsor:

Peking University First Hospital

Conditions:

Chronic Atrophic Gastritis

Eligibility:

All Genders

18-70 years

Brief Summary

This is an observational cohort study of clinical efficacy study.The purpose of this topic is to evaluate the efficacy and safety of Modified Liujunzi Decoction based on syndrome differentiation in pa...

Eligibility Criteria

Inclusion

  • Patients with CAG diagnosed by endoscopy and pathological examination, the pathological diagnosis criteria refer to the China consensus of chronic gastritis (2017) ;
  • Previous HP infection, HP negative after standardized treatment;
  • TCM syndrome differentiation mainly focuses on the weakness of the spleen and stomach,referring to the consensus on the diagnosis and treatment of chronic atrophic gastritis with integrated traditional Chinese and Western Medicine (2017), there is no restriction on concurrent syndrome;
  • Age 18-70 years old, regardless of gender;
  • The subject (or legal representative) voluntarily agreed and signed the informed consent form, and was able to abide by the study protocol during the study.

Exclusion

  • History of gastric surgery;
  • Combined with serious diseases affecting the study evaluation, such as serious liver disease, heart disease, kidney disease, malignant tumor and alcoholism;
  • Allergic to the drugs used in this study;
  • Participated in clinical research of other drugs in the first 3 months of the study;
  • Patients can't express correctly their subjective feelings and can't cooperate.

Key Trial Info

Start Date :

August 2 2022

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 31 2025

Estimated Enrollment :

286 Patients enrolled

Trial Details

Trial ID

NCT05388890

Start Date

August 2 2022

End Date

December 31 2025

Last Update

September 5 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Peking University First Hospital

Beijing, Beijing Municipality, China, 100034